Search Ontology:
ChEBI

EC 4.1.1.15 (glutamate decarboxylase) inhibitor

Term ID
CHEBI:142581
Synonyms
  • aspartate 1-decarboxylase inhibitor
  • aspartate 1-decarboxylase inhibitors
  • aspartic alpha-decarboxylase inhibitor
  • aspartic alpha-decarboxylase inhibitors
  • cysteic acid decarboxylase inhibitor
  • cysteic acid decarboxylase inhibitors
  • EC 4.1.1.15 (glutamate decarboxylase) inhibitors
  • EC 4.1.1.15 inhibitor
  • EC 4.1.1.15 inhibitors
  • gamma-glutamate decarboxylase inhibitor
  • gamma-glutamate decarboxylase inhibitors
  • glutamate decarboxylase (EC 4.1.1.15) inhibitor
  • glutamate decarboxylase (EC 4.1.1.15) inhibitors
  • glutamate decarboxylase inhibitor
  • glutamate decarboxylase inhibitors
  • L-aspartate-alpha-decarboxylase inhibitor
  • L-aspartate-alpha-decarboxylase inhibitors
  • L-glutamate 1-carboxy-lyase (4-aminobutanoate-forming) inhibitor
  • L-glutamate 1-carboxy-lyase (4-aminobutanoate-forming) inhibitors
  • L-glutamate 1-carboxy-lyase inhibitor
  • L-glutamate 1-carboxy-lyase inhibitors
  • L-glutamate alpha-decarboxylase inhibitor
  • L-glutamate alpha-decarboxylase inhibitors
  • L-glutamic acid decarboxylase inhibitor
  • L-glutamic acid decarboxylase inhibitors
  • L-glutamic decarboxylase inhibitor
  • L-glutamic decarboxylase inhibitors
(all 27)
Definition
An EC 4.1.1.* (carboxy-lyase) inhibitor that interferes with the action of glutamate decarboxylase (EC 4.1.1.15).
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse has_role
Phenotype
Phenotype resulting from EC 4.1.1.15 (glutamate decarboxylase) inhibitor
Phenotype where environments contain EC 4.1.1.15 (glutamate decarboxylase) inhibitor
Phenotype modified by environments containing EC 4.1.1.15 (glutamate decarboxylase) inhibitor
Phenotype affecting EC 4.1.1.15 (glutamate decarboxylase) inhibitor
Human Disease Model
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.